Back
FactSet Research Systems Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Buy
56
FDS
FactSet Research Systems
Last Price:
461.67
Seasonality Move:
7.75%
Buy
70
MDGL
Madrigal Pharmaceuticals
Last Price:
331.02
Seasonality Move:
31.67%
Buy
56
FactSet Research Systems (FDS)
is a Buy
Is FactSet Research Systems a Buy, Sell or Hold?
- The current FactSet Research Systems [FDS] share price is $461.81. The Score for FDS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- FDS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $331.32. The Score for MDGL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDS Stock Price Chart
What is FactSet Research Systems's stock price today?
-
The FactSet Research Systems share price today is $461.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $331.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.
FDS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.02 | Buy |
| Relative Strength Index (14 RSI): | 54.66 | Buy |
| Chaikin Money Flow: | 208073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (454.05 - 465.25) | Buy |
| Bollinger Bands (100): | (408.74 - 454.26) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.42 | Buy |
| Relative Strength Index (14 RSI): | 86.69 | Buy |
| Chaikin Money Flow: | 576514 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (190.5 - 254.66) | Buy |
| Bollinger Bands (100): | (221.16 - 280.26) | Buy |
FDS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 457.43 | Buy |
| 20-day SMA: | 460.16 | Buy |
| 50-day SMA: | 449.31 | Buy |
| 200-day SMA: | 439.49 | Buy |
| 8-day EMA: | 458.99 | Buy |
| 20-day EMA: | 458.68 | Buy |
| 50-day EMA: | 449.98 | Buy |
| 200-day EMA: | 438.04 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 246.83 | Buy |
| 20-day SMA: | 225.95 | Buy |
| 50-day SMA: | 229.96 | Buy |
| 200-day SMA: | 241.65 | Buy |
| 8-day EMA: | 263.88 | Buy |
| 20-day EMA: | 237.89 | Buy |
| 50-day EMA: | 234.01 | Buy |
| 200-day EMA: | 235.45 | Buy |
FactSet Research Systems Earnings Growth & FDS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.22 per share, and an increase next year of $0.86 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.19 per share, and an increase next year of $9.06 per share.
FactSet Research Systems Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||